Increased sensitivity of prediabetic nonobese diabetic mouse to the behavioral effects of IL-1

Brain, Behavior, and Immunity

Volumn 13, Issue 4, 1999, Pages 303-314

  Bluthé, Rose Marie ^a   Jafarian Tehrani, Mehrnaz ^b   Michaud, Bruno ^a   Haour, France ^c   Dantzer, Robert ^a   Homo Delarche, Francoise ^d  

^a INSTITUT FRANÇOIS MAGENDIE   (France)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c HÔPITAL SAINT ANTOINE   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Behavior; Brain IL 1 receptors; Infection; Interleukin 1 (IL 1); NOD mouse; Stress

Indexed keywords

BRAIN RECEPTOR; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; ENVIRONMENTAL FACTOR; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INFECTION; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MOUSE; PRIORITY JOURNAL; RECEPTOR GENE;

EID: 0033430177     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1006/brbi.1998.0542     Document Type: Article

References (63)

1. Ader D. N., Bennett-Johnson S., Huang S. W., Riley W. J. Group size, cage shelf level, and emotionality in nonobese diabetic mice : impact on onset and incidence of IDDM. Psychosom. Med. 53:1991;313-321.
2. Amrani A., Homo-Delarche F., Dardenne M., Pléau J. M. PCR analysis of interleukin-1 receptor gene in the nonobese diabetic mouse. Eur. Cytokine Netw. 6:1995;103-107.
3. Amrani A., Jafarian-Tehrani M., Mormede P., Durant S., Pléau J. M., Haour F., Dardenne M., Homo-Delarche F. Interleukin-1 effect on glycemia in the non-obese diabetic mouse at the pre-diabetic stage. J. Endocrinol. 148:1996;139-148.
4. Atkinson M. A., MacLaren N. K. The pathogenesis of insulin-dependent diabetes mellitus. N. Engl. J. Med. 331:1994;1428-1436.
5. Bach J. F. Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr. Rev. 15:1994;516-542.
6. Ban E., Milon G., Prudhomme N., Fillion G., Haour F. Receptors for interleukin-1 (alpha and beta) in mouse brain: mapping and neuronal localization in hippocampus. Neuroscience. 43:1991;21-30.
7. Bennett S. T., Todd J. A. Human type 1 diabetes and the insulin gene: principles of mapping polygenes. Annu. Rev. Genet. 30:1996;343-370.
8. Bergholdt R., Karlsen A. E., Johannesen J., Hansen P. M., Dinarello C. A., Nerup J., Pociot F. Characterization of polymorphisms of an interleukin 1 receptor type 1 gene (IL1RI) promotor region (P2) and their relation to insulin-dependent diabetes mellitus (IDDM). The Danish Study Group of Diabetes in Childhood. Cytokine. 7:1995;727-733.
9. Besedovsky H. O., Del Rey A. Immune-neuro-endocrine interactions: Facts and hypotheses. Endocr. Rev. 17:1996;64-102.
10. Bluthé R. M., Parnet P., Dantzer R., Kelley K. W. Interleukin-1 receptor antagonist blocks effects of IL-1 alpha and IL-1 beta on social behaviour and body weight in mice. Neurosci. Res. Commun. 9:1991;151-158.
11. Bluthé R. M., Michaud B., Kelley K. W., Dantzer R. Vagotomy blocks behavioural effects of interleukin-1 injected via the intraperitoneal route but not via other systemic routes. NeuroReport. 7:1996;2823-2827.
12. Bluthé R. M., Michaud B., Delhaye-Bouchaud N., Mariani J., Dantzer R. Hypersensitivity of lurcher mutant mice to the depressing effects of lipopolysaccharide and interleukin-1 on behaviour. NeuroReport. 8:1997;1119-1122.
13. Busbridge N. J., Grossman A. B. Stress and the single cytokine: interleukin modulation of the pituitary-adrenal axis. Mol. Cell. Endocrinol. 82:1991;C209-C214.
14. Connor T. J., Leonard B. E. Depression, stress and immunological activation: the role of cytokines in depressive disorders. Life Sci. 62:1998;583-606.
15. Cornell R. P., Schwartz D. B. Central administration of interleukin 1 elicits hyperinsulinemia in rats. Am. J. Physiol. 256:1989;R772-R777.
16. Cunningham Et J. R., de Souza E. B. Interleukin 1 receptors in the brain and endocrine tissues. Immunol. Today. 14:1993;171-176.
17. Dantzer R., Bluthé R. M., Aubert A., Goodall G., Bret-Dibat J. L., Kent S., Goujon E., Layé S., Parnet P., Kelley K. W. Cytokine actions on behavior. Rothwell N. J. Cytokines in the nervous system. 1996;117-144 Landes, Austin.
18. Dayer-Metroz M. D., Duhamel D., Rufer N., Izui S., Carmichaels D., Wollheim C. B., Thompson R. C., Dayer J. M. IL-1 receptor antagonist delays spontaneous autoimmune diabetes in BB rats. Eur. J. Clin. Invest. 22:1992;A50-A50.
19. Derijk R., Berkenbosch F. The immune hypothalamo-pituitary-adrenal axis and autoimmunity. Int. J. Neurosci. 59:1991;91-100.
20. Dinarello C. A. Biologic basis for interleukin-1 in disease. Blood. 87:1996;2095-2147.
21. Durant S., Coulaud J., Amrani A., El Hasnaoui A., Dardenne M., Homo-Delarche F. Effects of various environmental stress paradigms and adrenalectomy on the expression of autoimmune type 1 diabetes in the non-obese diabetic (NOD) mouse. J. Autoimmun. 6:1993;735-751.
22. Field L. L., Tobias R. Unravelling a complex trait: The genetics of insulin-dependent diabetes mellitus. Clin. Invest. Med. 20:1997;41-49.
23. Fitzpatrick F., Lepault F., Homo-Delarche F., Bach J. F., Dardenne M. Influence of castration, alone or combined with thymectomy, on the development of diabetes in the nonobese diabetic mouse. Endocrinology. 129:1991;1382-1390.
24. Gabellec M. M., Griffais R., Fillion G., Haour F. Expression of interleukin 1 alpha, interleukin 1 beta and interleukin 1 receptor antagonist mRNA in mouse brain: Regulation by bacterial lipopolysaccharide (LPS) treatment. Mol. Brain Res. 31:1995;122-130.
25. Goujon E., Parnet P., Layé S., Combe C., Kelley K. W., Dantzer R. Stress downregulates lipopolysaccharide-induced expression of proinflammatory cytokines in the spleen, pituitary, and brain of mice. Brain Behav. Immun. 9:1995;292-303.
26. Haour F. G., Ban E. M., Milon G. M., Baran D., Fillion G. M. Brain interleukin 1 receptors: characterization and modulation after lipopolysaccharide injection. Prog. NeuroEndocrinImmunol. 3:1990;196-204.
27. Homo-Delarche F. Beta-cell behaviour during the prediabetic stage. Part II. Non-insulin-dependent and insulin-dependent diabetes mellitus. Diabetes Metab. 23:1997;473-505.
28. Homo-Delarche F., Durant S. Hormones, Neurotransmitters and neuropeptides as modulators of lymphocyte functions. Rola-Pleszczynski M. Immunopharmacology of lymphocytes: Handbook of immunopharmacology. 1994;171-240 Academic Press, London.
29. Jacob C. O., Aiso S., Michie S. A., McDevitt H. O., Acha-Orbea H. Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): Similarities between TNF-alpha and interleukin 1. Proc. Natl. Acad. Sci. USA. 87:1990;968-972.
30. Jafarian-Tehrani M., Hu Y., Marquette C., Dietrich H., Haour F., Wick G. Interleukin-1 receptor deficiency in brains from NZB and (NZB/NZW)F1 autoimmune mice. J. Neuroimmunol. 53:1994;91-99.
31. Jafarian-Tehrani M., Amrani A., Homo-Delarche F., Marquette C., Dardenne M., Haour F. Localization and characterization of interleukin-1 receptors in the islets of Langerhans from control and nonobese diabetic mice. Endocrinology. 136:1995;609-613.
32. Jafarian-Tehrani M., Gabellec M. M., Adyel F. Z., Simon D., Griffais R., Ternynck T., Haour F. Interleukin-1 receptor deficiency in the hippocampal formation of (NZB × NZW)F2 mice: Genetic and molecular studies relating to autoimmunity. J. Neuroimmunol. 84:1998;30-39.
33. Jansen A., Homo-Delarche F., Hooijkaas H., Leenen P. J., Dardenne M., Drexhage H. A. Immunohistochemical characterization of monocytes-macrophages and dendritic cells involved in the initiation of the insulitis and beta-cell destruction in NOD mice. Diabetes. 43:1994;667-675.
34. Kikutani H., Makino S. The murine autoimmune diabetes model: NOD and related strains. Adv. Immunol. 51:1992;285-322.
35. Lang C. H., Molina P. E., Yousef K. A., Tepper P. G., Abumrad N. N. Role of IL-1alpha in central nervous system immunomodulation of glucoregulation. Brain Res. 624:1993;53-60.
36. Lehmann A. Atlas stereotaxique du cerveau de la souris. 1974;CNRS, Paris.
37. Like A. A., Guberski D. L., Butler L. Influence of environmental viral agents on frequency and tempo of diabetes mellitus in BB/Wor rats. Diabetes. 40:1991;259-262.
38. Luan J. J., Monteiro R. C., Sautes C., Fluteau G., Eloy L., Fridman W. H., Bach J. F., Garchon H. J. Defective Fc gamma RII gene expression in macrophages of NOD mice: Genetic linkage with up-regulation of IgG1 and IgG2b in serum. J. Immunol. 157:1996;4707-4716.
39. Mandrup-Poulsen T., Zumsteg U., Reimers J., Pociot F., Morch L., Helqvist S., Dinarello C. A., Nerup J. Involvement of interleukin 1 and interleukin 1 antagonist in pancreatic beta-cell destruction in insulin-dependent diabetes mellitus. Cytokine. 5:1993;185-191.
40. Mandrup-Poulsen T., Pociot F., Molvig J., Shapiro L., Nilsson P., Emdal T., Roder M., Kjems L. L., Dinarello C. A., Nerup J. Monokine antagonism is reduced in patients with IDDM. Diabetes. 43:1994;1242-1247.
41. Mandrup-Poulsen T. The role of interleukin-1 in the pathogenesis of IDDM. Diabetologia. 39:1996;1005-1029.
42. Netea M. G., Hancu N., Blok W. L., Grigorescu-Sido P., Popa L., Popa V., Van Der Meer J. W. Interleukin 1 beta, tumour necrosis factor-alpha and interleukin 1 receptor antagonist in newly diagnosed insulin-dependent diabetes mellitus: comparison to long-standing diabetes and healthy individuals. Cytokine. 9:1997;284-287.
43. Nicoletti F., Di Marco R., Barcellini W., Magro G., Schorlemmer H. U., Kurrle R., Lunetta M., Grasso S., Zaccone P., Meroni P. Protection from experimental autoimmune diabetes in the non-obese diabetic mouse with soluble interleukin-1 receptor. Eur. J. Immunol. 24:1994;1843-1847.
44. Pankewycz O. G., Guan J. X., Benedict J. F. Cytokines as mediators of autoimmune diabetes and diabetic complications. Endocr. Rev. 16:1995;164-176.
45. Petit F., Jarrous A., Dickinson R. D., Molina P. E., Abumrad N. N., Lang C. H. Contribution of central and peripheral adrenergic stimulation to IL-1 alpha-mediated glucoregulation. Am. J. Physiol. 267:1994;E49.
46. Pozzilli P., Signore A., Williams A. J., Beales P. E. NOD mouse colonies around the world - recent facts and figures. Immunol. Today. 14:1993;193-196.
47. Prins J. B., Todd J. A., Rodrigues N. R., Ghosh S., Hogarth P. M., Wicker L. S., Gaffney E., Podolin P. L., Fischer P. A., Sirotina A., Peterson L. B. Linkage on chromosome 3 of autoimmune diabetes and defective Fc receptor for IgG in NOD mice. Science. 260:1993;695-698.
48. Purello F., Buscema M. Effects of interleukin-1beta on insulin secretion by pancreatic beta-cells. Diabetes Nutr. Metab. 6:1993;295-304.
49. Rabinovitch A. Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM. Therapeutic intervention by immunostimulation? Diabetes. 43:1994;613-621.
50. Sandberg J. O., Andersson A., Eizirik D. L., Sandler S. Interleukin-1 receptor antagonist prevents low dose streptozotocin induced diabetes in mice. Biochem. Biophys. Res. Commun. 202:1994;543-548.
51. Saravia-Fernandez F., Durant S., El Hasnaoui A., Dardenne M., Homo-Delarche F. Environmental and experimental procedures leading to variations in the incidence of diabetes in the nonobese diabetic (NOD) mouse. Autoimmunity. 9:1996;341-348.
52. Satoh J., Seino H., Abo T., Tanaka S. I., Shintani S., Ohta S., Tamura K., Sawai T., Nobunaga T., Oteki T., Kumagai K., Toyota T. Recombinant human tumor necrosis factor alpha suppresses autoimmune diabetes in nonobese diabetic mice. J. Clin. Invest. 84:1989;1345-1348.
53. Scott F. W., Elliott R. B., Kolb H. Diet and autoimmunity: prospects of prevention of type I diabetes. Diabetes Nutr. Metab. 2:1989;61-73.
54. Serreze D. V., Leiter E. H. Insulin-dependent diabetes mellitus in NOD mice and BB rats: origins in hematopoietic stem cell defects and implications for therapy. Shafrir E. Lessons from animal diabetes. 1995;59-73 Smith-Gordon, London.
55. Serreze D. V., Leiter E. H. Defective activation of T suppressor cell function in nonobese diabetic mice. Potential relation to cytokine deficiencies. J. Immunol. 140:1988;3801-3807.
56. Shimomura Y., Inukai T., Kuwabara A., Shimizu H., Sato N., Uehara Y., Kobayashi I., Kobayashi S. Enhanced sensitivity to anorexia and consumption of drinking water induced by interleukin-1 beta in obese yellow mice. Eur. J. Pharmacol. 209:1991;15-18.
57. Shintani F., Nakaki T., Kanba S., Kato R., Asai M. Role of interleukin-1 in stress responses. A putative neurotransmitter. Mol. Neurobiol. 10:1995;47-71.
58. Singh B., Rabinovitch A. Influence of microbial agents on the development and prevention of autoimmune diabetes. Autoimmunity. 15:1993;209-213.
59. Takao T., Hashimoto K., de Souza E. B. Modulation of interleukin-1 receptors in the brain-endocrine-immune axis by stress and infection. Brain Behav. Immun. 9:1995;276-291.
60. Tilders F. J. H., Derijk R. H., Van Dam A. M., Vincent V. A. M., Schotanus K., Persoons J. H. A. Activation of the hypothalamus-pituitary-adrenal axis by bacterial endotoxins: routes and intermediate signals. Psychoneuroendocrinology. 19:1994;209-232.
61. Van Gool J., Van Vugt H., Helle M., Aarden L. A. The relation among stress, adrenalin, interleukin 6 and acute phase proteins in the rat. Clin. Immunol. Immunopathol. 57:1990;200-210.
62. Wiegers G. J., Reul J. M. H. M. Induction of cytokine receptors by glucocorticoids: Functional and pathological significance. Trends Pharmacol. Sci. 19:1998;317-321.
63. Williams A. J. K., Krug J., Lampeter E. F., Mansfield K., Beales P. E., Signore A., Gale E. A. M., Pozzilli P. Raised temperature reduces the incidence of diabetes in the NOD mouse. Diabetologia. 33:1990;635-637.